Ephedrannin A



Compound IDCDAMM02742
Common nameEphedrannin A
IUPAC name6,9,17,19,21-pentahydroxy-5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),5,9,15,17,19-heptaen-7-one
Molecular formulaC30H20O11

Experimental data

Retention time11.75
Adduct[M+Na]+
Actual mz579.089
Theoretical mz579.09
Error1.41
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.6014

Identifiers and class information

Inchi keyGPBSBBVDERLESN-KWRBWDCJNA-N
SmilesO=C1C(O)=C(OC=2C1=C(O)C=C3OC4(OC=5C=C(O)C=C(O)C5C(C32)C4O)C6=CC=C(O)C=C6)C=7C=CC(O)=CC7
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)556.481
Computed dipole moment(dipole)9.455
Total solvent accessible surface area (SASA)774.799
Hydrophobic component of SASA (FOSA)15.729
Hydrophilic component of SASA (FISA)341.692
Pie component of the SASA (PISA)417.378
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1448.31
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)9.2
Free energy of solvation of dipole (dip^2/V)0.0617204
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0290854
Globularity descriptor (glob)0.799007
Predicted polarizability in cubic angstroms (QPpolrz)51.299
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.424
Predicted octanol/gas partition coefficient (QPlogPoct)32.902
Predicted water/gas partition coefficient (QPlogPw)23.053
Predicted octanol/water partition coefficient (QPlogPo/w)1.878
Predicted aqueous solubility (QPlogS)-5.441
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.164
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.775
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)5.697
Predicted brain/blood partition coefficient (QPlogBB)-3.427
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.855
Predicted skin permeability, log Kp (QPlogKp)-5.675
PM3 calculated ionization potential (IP(ev))8.59
PM3 calculated electron affinity (EA(eV))0.509
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.217
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)12.592
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)191.125
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P05164MPOMyeloperoxidaseT23471SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P11474ESRRAEstrogen-related receptor alphaT72841SEA
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P49763PGFPlacenta growth factorT70792SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q9NPH5NOX4NADPH oxidase 4T29741SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
Q04760GLO1Glyoxalase IT88285SEA
Q9HC98NEK6Serine/threonine-protein kinase NEK6T78992SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q15717ELAVL1ELAV-like protein 1T78349SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T23471DI0229Left ventricular failure[ICD-11: BD11]P05164MPO
T23471DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P05164MPO
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T72841DI0366Rheumatoid arthritis[ICD-11: FA20]P11474ESRRA
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T29741DI0146Fibrosis[ICD-11: GA14-GC01]Q9NPH5NOX4
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS

Copyright © 2025